Journal article icon

Journal article

The next chapter for group B meningococcal vaccines

Abstract:

The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter a new era, with the first routine program underway to control endemic group B meningococcal disease for infants in the UK, it is timely to review the key landmarks in group B vaccine development, a...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Oxford college:
St Cross College
Role:
Author
More from this funder
Name:
National Institute for Health Research Oxford Biomedical Research Centre
Funding agency for:
Pollard, A
Publisher:
Taylor and Francis
Journal:
Critical Reviews in Microbiology More from this journal
Volume:
44
Issue:
1
Pages:
95-111
Publication date:
2017-05-30
Acceptance date:
2017-04-19
DOI:
EISSN:
1549-7828
ISSN:
1040-841X
Language:
English
Keywords:
Pubs id:
pubs:697735
UUID:
uuid:c7dfefb0-445c-4b8e-be3c-13d3799edad7
Local pid:
pubs:697735
Source identifiers:
697735
Deposit date:
2017-06-02

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP